INSM Q3 2019 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$39M

Gross Profit

$32M83.4% margin

Operating Income

-$56M-145.3% margin

Net Income

-$61M-156.1% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

+29.7%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$67M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$763M

Total Liabilities

$459M

Stockholders' Equity

$304M

Cash & Equivalents

$536M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$0	—
Gross Profit	$32M	$0	—
Operating Income	-$56M	-$84M	+32.7%
Net Income	-$61M	-$88M	+30.8%